Warning Letters And Close-Outs – March 2023
Executive Summary
The US FDA released three device-related closeout letters in March, resolving past citations against Polymer Technology Systems, Skin Sheek and WHPM Inc. Additionally, a new warning letter was issued to Olympus Medical Systems.
You may also be interested in...
AMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification
A new voluntary certification from the AMR Industry Alliance and the British Standards Institution will assess pharmaceutical firms’ responsibility and sustainability when it comes to manufacturing antibiotic drugs, in an attempt to control the spread of antimicrobial resistance.
Exec Chat: PacBio Addresses Latest Results, New Tech And Long-Read Sequencing’s Future
PacBio has been burning through investors’ cash as it works to make long-read sequencing more accessible. Neil Ward, the company’s general manager, laid out his thoughts on the technology, its place in the market and how genomics data can be both effectively and fairly utilized.
MedTech Forum 2023: Europe’s Regulatory Maze Must Be Simplified, But How?
Navigating Europe’s increasingly complex maze of regulations was the topic du jour at this year’s MedTech Forum conference. Despite growing concerns that the EU is losing its historic attractiveness for companies, a spirit of resilience characterized the busy two-day meeting.